PEGASUS - Improving Treatment for Patients With Emotionally Unstable Personality Disorder

The purpose of the PEGASUS study is to conduct a pilot trial to test the feasibility and acceptability of the PEGASUS intervention, adding a case manager and family-based interventions meetings to the existing psychiatric integrated care-models known as "Treatment Packages" in Denmark. We will conduct a randomized, assessor-blinded parallel-groups superiority clinical trial, testing the PEGASUS intervention for emotionally unstable personality disorder "EUPD", borderline type (borderline personality disorder) compared to "Treatment as Usual" before moving on to testing in a full-scale trial. Participants will be assessed at baseline and 9 month post baseline at study conclusion

NCT Number	NCT06563466
Lead Sponsor	University Hospital Bispebjerg and Frederiksberg Collaborators: Hvidovre University Hospital
Conditions	Borderline Personality Disorder, Relatives
Enrollment	100 participants
Start Date	2024-09-01
Primary Completion	2027-10-31 (estimated)
Study Completion	2029-08-31 (estimated)
Updated on ClinicalTrials.gov	2026-04-28